Literature DB >> 92379

A nephelometric study of the reaction of monoclonal rheumatoid factor with heat aggregated gamma globulin and sera from patients with immune complex diseases.

P J Roberts-Thomson, J Bradley.   

Abstract

Monoclonal rheumatoid factors (MCRF) have previously been used in a variety of assays for the detection of IgG-containing circulating immune complexes. We have isolated a MCRF from a patient with a lymphoproliferative disorder and have used a nephelometric technique to characterize its reaction with heat-aggreagated gammaglobulin (HAGG) used as a source of artificial immune complexes. The method is simple, economical and rapid and will detect as little as 6 microgram/ml of HAGG over a wide range of physicochemical conditions. A clinical study demonstrated that the sera from thirty-five out of fifty-eight patients (59%) with rheumatoid arthritis and twenty-one out of seventy-four patients (28%) with systemic lupus erythematosus (SLE) gave increased precipitation with MCRF compared with 232 blood donors. However, in marked contrast to previous studies, sucrose gradient ultracentrifugal analysis of nine strongly precipitating sera revealed that in eight the MCRF precipitated with material sedimenting in the monomeric IgG position. In only one specimen did the MCRF react with material sedimenting in heavier regions. It is suggested that different MCRFs vary in the specificity for binding IgG complexes and these reagents should be carefully characterized before becoming established in nephelometric assays for circulating immune complexes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92379      PMCID: PMC1537792     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Characteristics of soluble immune complexes prepared from oligovalent DNP conjugates and anti-DNP antibodies.

Authors:  A Kijlstra; D W Knutson; A van der Lelij; L A van Es
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 3.  Hypergammaglobulinemic purpura. Studies on the unusual anti- -globulins characteristic of the sera of these patients.

Authors:  J D Capra; R J Winchester; H G Kunkel
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

4.  Proceedings: Differences in serum IgG structure in health and rheumatoid arthritis as studied by circular dichroic spectra.

Authors:  P Johnson; J Watkins
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

5.  Routine assay for detection of IgG and IgM antiglobulins in seronegative and seropositive rheumatoid arthritis.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Br Med J       Date:  1975-07-26

6.  Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.

Authors:  H S Luthra; F C McDuffie; G G Hunder; E A Samayoa
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.

Authors:  A Gabriel; V Agnello
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  Immunoglobulin complexes in sera of patients with malignancy.

Authors:  E A Samayoa; F C McDuffie; A M Nelson; V L Go; H S Luthra; H W Brumfield
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

9.  Occurrence of -globulin complexes in serum and joint fluid of rheumatoid arthritis patients: use of monoclonal rheumatoid factors as reagents for their demonstration.

Authors:  R J Winchester; H G Kunkel; V Agnello
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

10.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

  10 in total
  6 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  Neutrophil activation by immune complexes and the role of rheumatoid factor.

Authors:  R Gale; J V Bertouch; T P Gordon; J Bradley; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

3.  IgA and temperature dependent IgG complex formation in a patient with Waldenström's hypergammaglobulinaemic purpura.

Authors:  P J Roberts-Thomson; A S Kemp
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

4.  A reappraisal of the monoclonal rheumatoid factor test for circulating immune complexes: a comparison of two monoclonal rheumatoid factor reagents.

Authors:  P J Roberts-Thomson
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

5.  Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid.

Authors:  R Gale; J V Bertouch; J Bradley; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

6.  Circulating and intra-articular immune complexes in rheumatoid arthritis: a comparative study of the C1q binding and monoclonal rheumatoid factor assays.

Authors:  P J Roberts-Thomson; S H Neoh; J Bradley; S C Milazzo
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.